Psoriasis: all 1,928 studies

Page 9 of 20. Open to participants first (234), then studies with results posted, then the rest; newest registration first within each.

• A Canadian Open-Label Access Program to Evaluate Adalimumab When Added to Inadequate Therapy for the Treatment of PsoriasisCompletedNCT00513370Phase 3Results posted
• Compare Perceptions and Satisfaction for Two Different Delivery Mechanisms for EtanerceptCompletedNCT00482170Phase 3Results posted
• Effects of TNF-alpha Antagonism (Etanercept) in Patients With the Metabolic Syndrome and PsoriasisTerminatedNCT00477191Not applicableResults posted
• Mechanistically-based Optimization of UV Radiation Therapy in PsoriasisTerminatedNCT00470392Not applicableResults posted
• Centocor Microarray Study of PatientsCompletedNCT00462072Phase 4Results posted
• An Efficacy and Safety Study of CNTO 1275 Compared to Etanercept in Patients With Plaque PsoriasisCompletedNCT00454584Phase 3Results posted
• Subject Preference for Scalp Psoriasis TreatmentCompletedNCT00438399Phase 3Results posted
• Efficacy and Safety of Cyclosporine A Microemulsion in Maintenance Patients With Chronic Plaque PsoriasisCompletedNCT00438360Phase 3Results posted
• Safety and Efficacy Study of CF101 to Treat PsoriasisCompletedNCT00428974Phase 2Results posted
• A Study of Calcitriol BID Topical Treatment in Adolescents With Plaque PsoriasisCompletedNCT00419666Phase 2Results posted
• Maintenance Effect of Clobex Shampoo on Participants With Moderate to Severe Scalp PsoriasisCompletedNCT00400725Phase 3Results posted
• Evaluate Whether Combination Therapy With Methotrexate and Raptiva in Psoriasis Patients is Safe and Increases EfficacyCompletedNCT00368654Phase 1/2Results posted
• Long-Term Effects of Infliximab in the Treatment of Moderate to Severe Psoriasis [Extension of Study P04271, NCT00251641] (P04563)TerminatedNCT00358670Phase 3Results posted
• Fluphenazine Decanoate for PsoriasisTerminatedNCT00356200Phase 2Results posted
• A Placebo-Controlled Double-Blind Study on the Safety and Efficacy of Etanercept in Palmoplantar PustulosisCompletedNCT00353119Phase 3Results posted
• A Study to Evaluate Raptiva in Subjects With Chronic Moderate or Worse Plaque Psoriasis Who Have Had an Inadequate Response to an Anti-TNF AgentCompletedNCT00336973Phase 4Results posted
• Canadian Assessment of Patient Outcomes and Effectiveness of Etanercept (Enbrel) in PsoriasisCompletedNCT00332332Phase 4Results posted
• Efficacy of Re-treatment With Cimzia® in Subject With Chronic Plaque PsoriasisCompletedNCT00329303Phase 2Results posted
• Observational Safety Study of Etanercept (Enbrel) for Treatment of PsoriasisCompletedNCT00322439Results posted
• A Safety and Effectiveness Study of CNTO 1275 in Patients With Moderate to Severe Plaque-type PsoriasisCompletedNCT00320216Phase 2Results posted
• A Study of the Safety and Efficacy of Ustekinumab (CNTO 1275) in Patients With Moderate to Severe PsoriasisCompletedNCT00307437Phase 3Results posted
• Study Evaluating the Cost of the Treatments of the Refractory Psoriatic Arthritis to the Conventional TherapyCompletedNCT00303186Results posted
• Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by RheumatologistsCompletedNCT00293722Results posted
• Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by DermatologistsCompletedNCT00293709Results posted
• A Multicentre, Open Label Phase IIIb/IV Study of Subcutaneously Administered Raptiva in the Treatment of Adult Subjects With Moderate to Severe Plaque PsoriasisCompletedNCT00287118Phase 4Results posted
• A Study of Safety and Effectiveness of Ustekinumab (CNTO 1275) in Patients With Moderate to Severe Plaque-type PsoriasisCompletedNCT00267969Phase 3Results posted
• Infliximab in High Need Versus Low Need Psoriasis Patients: The IHELP Study (Study P04320)(COMPLETED)CompletedNCT00254982Phase 3Results posted
• The Effects of Infliximab Versus Methotrexate in the Treatment of Moderate to Severe Psoriasis (Study P04271AM2)(COMPLETED)CompletedNCT00251641Phase 3Results posted
• A Study of Efalizumab in Participants With Moderate to Severe Chronic Psoriasis Who Have Failed, Have a Contraindication to, or Are Intolerant of Other Systemic TherapiesCompletedNCT00249808Phase 4Results posted
• Efficacy Study of CDP870 in Subjects With Chronic Plaque Psoriasis Who Are Candidate for Systemic Therapy and/or Phototherapy/PhotochemotherapyCompletedNCT00245765Phase 2Results posted
• Randomized Placebo-controlled Study of ISA247 in Plaque PsoriasisCompletedNCT00244842Phase 3Results posted
• Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque PsoriasisCompletedNCT00195676Phase 3Results posted
• Study Evaluating Etanercept in the Treatment of Subjects With PsoriasisCompletedNCT00195507Phase 4Results posted
• Acitretin and Etanercept in PsoriasisCompletedNCT00156247Phase 2Results posted
• Neuroskin Forte for Dry Skin Relief in Eczema and PsoriasisTerminatedNCT00143819Phase 2Results posted
• Pediatric Open-Label Extension Study of Etanercept in Patients With Plaque PsoriasisCompletedNCT00141921Phase 3Results posted
• Study of the Drug Efalizumab (Raptiva), for Adult Patients With Moderate to Severe Plaque PsoriasisCompletedNCT00115076Phase 3Results posted
• Etanercept (Enbrel®) in Psoriasis - PediatricsCompletedNCT00078819Phase 3Results posted
• Oral and Topical Phytocannabinoids for PsoriasisActive, not recruitingNCT07839455Phase 2
• Comparative Efficacy of Alpha Hydroxy Acids With and Without Nanocarriers Versus Calcipotriol Plus Betamethasone in Treatment of Plaque PsoriasisCompletedNCT07816575Not applicable
• A Study to Evaluate the Efficacy and Safety of LZM012 ( Psoriasis )CompletedNCT07746479Phase 3
• HPP737 in Adult Patients With Plaque PsoriasisCompletedNCT07712731Phase 3
• HPP737 in Adult Patients With Moderate-to-severe Plaque Psoriasis.CompletedNCT07712705Phase 3
• Psoriasis and Its Impact on Quality of Life Among Psoriatic PatientsCompletedNCT07709169
• Safety and Efficacy of HPP737 in Adult Patients With Plaque PsoriasisCompletedNCT07707141Phase 2
• Trial of HSK44459 Cream for the Management Plaque PsoriasisActive, not recruitingNCT07623486Phase 1/2
• Impact of Clinical and Psychological Factors on Satisfaction With Treatment in Psoriatic Patients on Biological TherapyCompletedNCT07498543
• A Study of Guselkumab After Switching From Ustekinumab in Participants With Moderate to Severe PsoriasisTerminatedNCT07449234
• Treatment of Psoriasis With Depression and/or Anxiety With Methotrexate vs Combined Methotrexate and AntidepressantCompletedNCT07432815Phase 4
• Using Artificial Intelligence to Help Doctors Identify Different Skin Conditions and Improve Patient CareCompletedNCT07428954
• Evaluating Legit.Health Plus Support for Improving Diagnosis of Generalized Pustular Psoriasis and Other Skin Conditions Among Primary Care Physicians and DermatologistsCompletedNCT07428915
• Combined Use of Cyclosporine and Metformin in Treatment of Psoriasis vs Cyclosporine AloneCompletedNCT07375654Phase 1
• Maximal Usage Pharmacokinetics and Safety Study of ARQ-154 Foam 0.3% in Pediatric Participants With Scalp and Body PsoriasisCompletedNCT07340216Phase 1
• Machine Learning-Based Prediction of Insulin Resistance in Psoriasis Patients Emphasizing InterpretabilityActive, not recruitingNCT07321288
• A Clinical Trial of TQH2929 Injection in Patients With Acute Flare-up of Generalized Pustular PsoriasisTerminatedNCT07314060Phase 2
• Shared Pathways Between Non-Alcoholic Fatty Liver Disease and Psoriatic Disease With Guselekumab TherapyWithdrawnNCT07255781
• Pharmacokinetic, Safety and Immunogenicity Study of New Process CMAB015 and Cosentyx in Healthy VolunteersCompletedNCT07254325Phase 1
• Tilrdakizumab AlmirallActive, not recruitingNCT07244744
• A Study to Evaluate How the Study Drug Moves Through the Body, Adverse Events, and How the Body Tolerates ABBV-547 InjectionsActive, not recruitingNCT07232004Phase 1
• A Trial of Academic Detailing to Promote Prescribing of BiosimilarsActive, not recruitingNCT07221890Not applicable
• A Drug-Drug Interaction Study Between HS-10374 Tablets and Drospirenone and Ethinyl Estradiol Tablets(Yasmin®)CompletedNCT07181343Phase 1
• Effects of IL17/23 Inhibitors on Markers of Subclinical Atherosclerosis in Patients With PsoriasisCompletedNCT07169682
• Periodontal Health and Quality of Life in Psoriasis PatientsCompletedNCT07154420
• Analysis of Influence Factors on Osteopenia in Different Treatment of PsoriasisCompletedNCT07140666
• Prediction Model for Osteopenia in Patients With PsoriasisCompletedNCT07112755
• A Trial of SHR-1139 in Healthy VolunteersActive, not recruitingNCT07078695Phase 1
• A Clinical Evaluation of Marula-Derived Ceramide Cream on Skin Barrier Function EnhancementCompletedNCT07066150Not applicable
• The Impact of Untreated Depression and Anxiety Among Patients With Skin Diseases in Jeddah, Saudi Arabia.CompletedNCT07046039
• Ten-Year Biologic Drug Survival in Psoriasis: Role of Genetic and Cardiometabolic PredictorsCompletedNCT07041112
• Interleukin-6 in Plaque Psoriasis and Its Possible Role in Disease SeverityCompletedNCT07001904
• Efficacy and Tolerability of Deucravacitinib in the Management of Palmoplantar PustulosisTerminatedNCT07000630Not applicable
• Evaluation of Salivary and Serum Levels of TNF-α, IL-17A, and YKL-40 in Individuals With PsoriasisActive, not recruitingNCT06984237
• A Phase II Clinical Study of AC-201 Tablets in Subjects With Plaque PsoriasisCompletedNCT06972888Phase 2
• A Study Comparing the Risk of Serious Infections and Malignancies With Deucravacitinib or Biologics in Japanese Patients With PsoriasisActive, not recruitingNCT06952465
• Exploratory Clinical Study on Fasting in Psoriasis and Psoriatic Arthritis (RiseFast)Active, not recruitingNCT06905028Not applicable
• Evaluation of TNF-α, IL-17A, and YKL-40 in GCF and Serum of Psoriasis Patients and Healthy ControlsActive, not recruitingNCT06897722
• Spesolimab Post-marketing Surveillance in Korean Patients With Flares With Generalized Pustular PsoriasisWithdrawnNCT06886009
• Interest of LC-OCT for Diagnosing Inflammatory Dermatoses: ODIN (OCT Dermotoses INflammatoires)CompletedNCT06874712
• Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque PsoriasisActive, not recruitingNCT06846541Phase 3
• A Study to Assess S011806 (DC-806 or LY4100504) in Healthy Adult Participants and Participants With Chronic Plaque PsoriasisCompletedNCT06808815Phase 1
• Evaluation of the Efficacy and Tolerance of the Medical Device RL3020-DP0364 in Adult Population With Stable Mild Plaque Psoriasis, Dry Skin and PruritusCompletedNCT06800755Not applicable
• IKBKB Gene Polymorphism (Single Nucleotide Polymorphism) (SNP) in Psoriatic and Psoriatic Arthritis PatientsCompletedNCT06729463Not applicable
• Evaluation of Safety and Efficacy of IRX4204 in Mild to Moderate Plaque PsoriasisSuspendedNCT06723171Phase 2
• A Study on the Safety of Deucravacitinib Exposure in Pregnant Women and Their OffspringActive, not recruitingNCT06710470
• Pythagorean Self-Awareness Intervention on Psoriasis Patients.CompletedNCT06691763Not applicable
• Psoriatic Disease and Related Manifestations; Real World Evidence in Brazilian Secukinumab EnvironmentCompletedNCT06666114
• Efficacy of Pulsed High Intensity Laser Therapy in Psoriatic Hand ArthritisCompletedNCT06665282Not applicable
• Hemoperfusion With Efferon CT for the Treatment of Patients With Severe PsoriasisCompletedNCT06640114Not applicable
• Bioequivalence Test of Hemay005 TabletsCompletedNCT06610903Phase 1
• Pharmacokinetic Interactions Between Hemay005 Tablets and Midazolam Maleate TabletsCompletedNCT06610890Phase 1
• A Phase 2 Study of HB0017 in Psoriasis PatientsCompletedNCT06592274Phase 2
• Efficacy and Safety of Infliximab Biosimilar in Treatment of Moderate to Severe Psoriasis; A Single-arm Clinical TrialActive, not recruitingNCT06591273Phase 1/2
• Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Moderate-to-Severe Plaque Psoriasis and Obesity or OverweightCompletedNCT06588283Phase 3
• Frequency of Tuberculosis in Psoriasis PatientsCompletedNCT06563635
• Topical 1% Methotrexate Gel Versus Clobetasol Propionate in Patients With PsoriasisCompletedNCT06555497Early Phase 1
• Blue Light in the Treatment of Inflammatory Skin DiseasesCompletedNCT06516783Not applicable
• Study of Efficacy and Safety of HB0017 in Patients With Moderate to Severe Plaque PsoriasisCompletedNCT06477237Phase 3
• Effect of Semaglutide on the Psoriatic Lesions in Patients With Type 2 Diabetes MellitusCompletedNCT06475586Phase 4
• An Open-label Controlled Trial: Effectiveness of Balneotherapy in Palmoplantar Psoriasis and Contact Dermatitis.CompletedNCT06458868Not applicable
• Association Between Apical Periodontitis and Psoriasis VulgarisCompletedNCT06436339

← Psoriasis overview